Literature DB >> 30565727

A full Bayesian model to handle structural ones and missingness in economic evaluations from individual-level data.

Andrea Gabrio1, Alexina J Mason2, Gianluca Baio1.   

Abstract

Economic evaluations from individual-level data are an important component of the process of technology appraisal, with a view to informing resource allocation decisions. A critical problem in these analyses is that both effectiveness and cost data typically present some complexity (eg, nonnormality, spikes, and missingness) that should be addressed using appropriate methods. However, in routine analyses, standardised approaches are typically used, possibly leading to biassed inferences. We present a general Bayesian framework that can handle the complexity. We show the benefits of using our approach with a motivating example, the MenSS trial, for which there are spikes at one in the effectiveness and missingness in both outcomes. We contrast a set of increasingly complex models and perform sensitivity analysis to assess the robustness of the conclusions to a range of plausible missingness assumptions. We demonstrate the flexibility of our approach with a second example, the PBS trial, and extend the framework to accommodate the characteristics of the data in this study. This paper highlights the importance of adopting a comprehensive modelling approach to economic evaluations and the strategic advantages of building these complex models within a Bayesian framework.
© 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Bayesian statistics; economic evaluations; hurdle models; missing data

Year:  2018        PMID: 30565727     DOI: 10.1002/sim.8045

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  6 in total

1.  The statistical approach in trial-based economic evaluations matters: get your statistics together!

Authors:  Elizabeth N Mutubuki; Mohamed El Alili; Judith E Bosmans; Teddy Oosterhuis; Frank J Snoek; Raymond W J G Ostelo; Maurits W van Tulder; Johanna M van Dongen
Journal:  BMC Health Serv Res       Date:  2021-05-19       Impact factor: 2.655

2.  Reference-based multiple imputation for missing data sensitivity analyses in trial-based cost-effectiveness analysis.

Authors:  Baptiste Leurent; Manuel Gomes; Suzie Cro; Nicola Wiles; James R Carpenter
Journal:  Health Econ       Date:  2019-12-17       Impact factor: 3.046

3.  Comparing methods for handling missing cost and quality of life data in the Early Endovenous Ablation in Venous Ulceration trial.

Authors:  Modou Diop; David Epstein
Journal:  Cost Eff Resour Alloc       Date:  2022-04-07

4.  Single-Inhaler Triple Therapy in Patients with Advanced COPD: Bayesian Modeling of the Healthcare Resource Utilization Data and Associated Costs from the IMPACT Trial.

Authors:  Andrea Gabrio; Necdet B Gunsoy; Gianluca Baio; Alan Martin; Victoria F Paly; Nancy Risebrough; David M G Halpin; Dave Singh; Robert A Wise; MeiLan K Han; Fernando J Martinez; Gerard J Criner; Neil Martin; David A Lipson; Afisi S Ismaila
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-07-25

5.  Linear mixed models to handle missing at random data in trial-based economic evaluations.

Authors:  Andrea Gabrio; Catrin Plumpton; Sube Banerjee; Baptiste Leurent
Journal:  Health Econ       Date:  2022-04-02       Impact factor: 2.395

6.  Cost-effectiveness and return-on-investment of C-reactive protein point-of-care testing in comparison with usual care to reduce antibiotic prescribing for lower respiratory tract infections in nursing homes: a cluster randomised trial.

Authors:  Tjarda M Boere; Mohamed El Alili; Laura W van Buul; Rogier M Hopstaken; Theo J M Verheij; Cees M P M Hertogh; Maurits W van Tulder; Judith E Bosmans
Journal:  BMJ Open       Date:  2022-09-15       Impact factor: 3.006

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.